Concepedia

Richard Finn

RF

Statistics

Publications

3

Citations

416

H-Index

3

Active since

1997

Affiliations

University of California, Los Angeles(Current)

Richard Finn is an author at University of California, Los Angeles specializing in medicine, oncology, and liver cancer.

Publications per year

1997–2025

3

Publications

3

The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells

Mark D. Pegram, Richard Finn, Karo K. Arzoo et al. · Oncogene · 1997 · 335 citations

Medicine, Cancer Biology, Oncology +14

Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b–2, study

Richard Finn, Baek‐Yeol Ryoo, Chih-Hung Hsu et al. · The Lancet Oncology · 2025 · 57 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Saudi Association for the Study of Liver diseases and Transplantation practice guidelines on the diagnosis and management of hepatocellular carcinoma

Saleh A. Alqahtani, Faisal M Sanai, Ashwaq Alolayan et al. · Saudi Journal of Gastroenterology · 2020 · 24 citations · Full text

Medicine, Internal Medicine, Oncology +17

1–3 of 3